| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |